Shares from interest rate sensitive auto, banking and realty sectors will be in focus ahead of the Reserve Bank of India's (RBI) monetary policy decision today, 5 October 2018. The resolution of the MPC will be unveiled at 14:30 IST today, 5 October 2018.
Pharma major Lupin announced the launch of Potassium Chloride Oral Solution USP, 20 mEq/15mL {10%) and 40 mEq/15 mL (20%), having received an approval from the United States Food and Drug Administration (FDA) earlier. The announcement was made after market hours yesterday, 4 October 2018.
Lupin's Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%), is the generic equivalent of Genus Lifesciences, Inc.'s Potassium Chloride Oral Solution. It is indicated for the treatment and prophylaxis of hypokalemia with or without metabolicalkalosis, in patients for whom dietary management with potassium-rich foods and/or diureticdose reduction are insufficient. Potassium Chloride Oral Solution had annual sales of approximately $184.95 million in the US {IQVIA MAT June 2018).
Cadila Healthcare said that the company's Biologics manufacturing facility (Zydus Biologics) located at the Zydus Biotech Park in Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA signifying the successful closure of the audit. The plant had completed the USFDA audit from 14th August to 24th August 2018 with Zero 483 observations. The announcement was made after market hours yesterday, 4 October 2018.
Dilip Buildcon has received Letter of Acceptance (LOA) for a new EPC project 'Navnera Barrage (Dam) under Phase I/(A)', valued at Rs 601.02 crore by the Water Resource Department, Kota, Rajasthan. The announcement was made after market hours yesterday, 4 October 2018.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)